Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Jun 30, 2024
Q2 FY2024
As of Mar 31, 2024
Q1 FY2024
As of Dec 31, 2023
Q4 FY2023
As of Sep 30, 2023
Q3 FY2023
As of Jun 30, 2023
Q2 FY2023
As of Mar 31, 2023
Q1 FY2023
As of Dec 31, 2022
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Prepaids and other current assets
Total current assets
Property and equipment, net
Goodwill
Intangible assets, net
Operating lease right-of-use assets
Other noncurrent assets
Total assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable
Accrued expenses
Operating lease liabilities
Long-term debt, current
Debt
Deferred revenue
Total current liabilities
Long-term debt, net of current
Operating lease liabilities, net of current
Deferred revenue, net of current
Warrant liabilities
Deferred tax liability
Total liabilities
Convertible preferred shares, par value of $0 per share; 0 and 41,883,053 shares issued and outstanding as of September 30, 2023 and September 30, 2022
Stockholders’ Deficit:
Ordinary shares, par value of $0.01 per share; 69,067,030 and 67,713,368 shares issued and outstanding as of June 30, 2024 and September 30, 2023
Additional paid-in-capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support